Cargando…
Monitoring of Unfractionated Heparin Therapy in the Intensive Care Unit Using a Point-of-Care aPTT: A Comparative, Longitudinal Observational Study with Laboratory-Based aPTT and Anti-Xa Activity Measurement
Continuous intravenous unfractionated heparin (UFH) is administered routinely in the intensive care unit (ICU) for the anticoagulation of patients, and monitoring is performed by the activated partial thromboplastin time (APTT) or anti-Xa activity. However, these strategies are associated with poten...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8911237/ https://www.ncbi.nlm.nih.gov/pubmed/35268436 http://dx.doi.org/10.3390/jcm11051338 |
_version_ | 1784666742399696896 |
---|---|
author | Lardinois, Benjamin Hardy, Michaël Michaux, Isabelle Horlait, Geoffrey Rotens, Thomas Jacqmin, Hugues Lessire, Sarah Bulpa, Pierre Dive, Alain Mullier, François |
author_facet | Lardinois, Benjamin Hardy, Michaël Michaux, Isabelle Horlait, Geoffrey Rotens, Thomas Jacqmin, Hugues Lessire, Sarah Bulpa, Pierre Dive, Alain Mullier, François |
author_sort | Lardinois, Benjamin |
collection | PubMed |
description | Continuous intravenous unfractionated heparin (UFH) is administered routinely in the intensive care unit (ICU) for the anticoagulation of patients, and monitoring is performed by the activated partial thromboplastin time (APTT) or anti-Xa activity. However, these strategies are associated with potentially large time intervals before dose adjustments, which could be detrimental to the patient. The aim of the study was to compare a point-of-care (POCT) version of the APTT to (i) laboratory-based APTT and (ii) measurements of anti-Xa activity in terms of correlation, agreement and turnaround time (TAT). Thirty-five ICU patients requiring UFH therapy were prospectively included and followed longitudinally for a maximum duration of 15 days. UFH was administered according to a local adaptation of Raschke and Amanzadeh’s aPTT nomograms. Simultaneous measurements of POCT-APTT (CoaguCheck(®) aPTT Test, Roche Diagnostics) on a drop of fresh whole blood, laboratory-based APTT (C.K. Prest(®), Stago) and anti-Xa activity (STA(®)Liquid anti-Xa, Stago) were systematically performed two to six times a day. Antithrombin, C-reactive protein, fibrinogen, factor VIII and lupus anticoagulant were measured. The time tracking of sampling and analysis was recorded. The overall correlation between POCT-APTT and laboratory APTT (n = 795 pairs) was strongly positive (rs = 0.77, p < 0.0001), and between POCT-APTT and anti-Xa activity (n = 729 pairs) was weakly positive (rs = 0.46, p < 0.0001). Inter-method agreement (Cohen’s kappa (k)) between POCT and laboratory APTT was 0.27, and between POCT and anti-Xa activity was 0.30. The median TATs from sample collection to the lab delivery of results for lab-APTT and anti-Xa were 50.9 min (interquartile range (IQR), 38.4–69.1) and 66.3 min (IQR, 49.0–91.8), respectively, while the POCT delivered results in less than 5 min (p < 0.0001). Although the use of the POCT-APTT device significantly reduced the time to results, the results obtained were poorly consistent with those obtained by lab-APTT or anti-Xa activity, and therefore it should not be used with the nomograms developed for lab-APTT. |
format | Online Article Text |
id | pubmed-8911237 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-89112372022-03-11 Monitoring of Unfractionated Heparin Therapy in the Intensive Care Unit Using a Point-of-Care aPTT: A Comparative, Longitudinal Observational Study with Laboratory-Based aPTT and Anti-Xa Activity Measurement Lardinois, Benjamin Hardy, Michaël Michaux, Isabelle Horlait, Geoffrey Rotens, Thomas Jacqmin, Hugues Lessire, Sarah Bulpa, Pierre Dive, Alain Mullier, François J Clin Med Article Continuous intravenous unfractionated heparin (UFH) is administered routinely in the intensive care unit (ICU) for the anticoagulation of patients, and monitoring is performed by the activated partial thromboplastin time (APTT) or anti-Xa activity. However, these strategies are associated with potentially large time intervals before dose adjustments, which could be detrimental to the patient. The aim of the study was to compare a point-of-care (POCT) version of the APTT to (i) laboratory-based APTT and (ii) measurements of anti-Xa activity in terms of correlation, agreement and turnaround time (TAT). Thirty-five ICU patients requiring UFH therapy were prospectively included and followed longitudinally for a maximum duration of 15 days. UFH was administered according to a local adaptation of Raschke and Amanzadeh’s aPTT nomograms. Simultaneous measurements of POCT-APTT (CoaguCheck(®) aPTT Test, Roche Diagnostics) on a drop of fresh whole blood, laboratory-based APTT (C.K. Prest(®), Stago) and anti-Xa activity (STA(®)Liquid anti-Xa, Stago) were systematically performed two to six times a day. Antithrombin, C-reactive protein, fibrinogen, factor VIII and lupus anticoagulant were measured. The time tracking of sampling and analysis was recorded. The overall correlation between POCT-APTT and laboratory APTT (n = 795 pairs) was strongly positive (rs = 0.77, p < 0.0001), and between POCT-APTT and anti-Xa activity (n = 729 pairs) was weakly positive (rs = 0.46, p < 0.0001). Inter-method agreement (Cohen’s kappa (k)) between POCT and laboratory APTT was 0.27, and between POCT and anti-Xa activity was 0.30. The median TATs from sample collection to the lab delivery of results for lab-APTT and anti-Xa were 50.9 min (interquartile range (IQR), 38.4–69.1) and 66.3 min (IQR, 49.0–91.8), respectively, while the POCT delivered results in less than 5 min (p < 0.0001). Although the use of the POCT-APTT device significantly reduced the time to results, the results obtained were poorly consistent with those obtained by lab-APTT or anti-Xa activity, and therefore it should not be used with the nomograms developed for lab-APTT. MDPI 2022-02-28 /pmc/articles/PMC8911237/ /pubmed/35268436 http://dx.doi.org/10.3390/jcm11051338 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Lardinois, Benjamin Hardy, Michaël Michaux, Isabelle Horlait, Geoffrey Rotens, Thomas Jacqmin, Hugues Lessire, Sarah Bulpa, Pierre Dive, Alain Mullier, François Monitoring of Unfractionated Heparin Therapy in the Intensive Care Unit Using a Point-of-Care aPTT: A Comparative, Longitudinal Observational Study with Laboratory-Based aPTT and Anti-Xa Activity Measurement |
title | Monitoring of Unfractionated Heparin Therapy in the Intensive Care Unit Using a Point-of-Care aPTT: A Comparative, Longitudinal Observational Study with Laboratory-Based aPTT and Anti-Xa Activity Measurement |
title_full | Monitoring of Unfractionated Heparin Therapy in the Intensive Care Unit Using a Point-of-Care aPTT: A Comparative, Longitudinal Observational Study with Laboratory-Based aPTT and Anti-Xa Activity Measurement |
title_fullStr | Monitoring of Unfractionated Heparin Therapy in the Intensive Care Unit Using a Point-of-Care aPTT: A Comparative, Longitudinal Observational Study with Laboratory-Based aPTT and Anti-Xa Activity Measurement |
title_full_unstemmed | Monitoring of Unfractionated Heparin Therapy in the Intensive Care Unit Using a Point-of-Care aPTT: A Comparative, Longitudinal Observational Study with Laboratory-Based aPTT and Anti-Xa Activity Measurement |
title_short | Monitoring of Unfractionated Heparin Therapy in the Intensive Care Unit Using a Point-of-Care aPTT: A Comparative, Longitudinal Observational Study with Laboratory-Based aPTT and Anti-Xa Activity Measurement |
title_sort | monitoring of unfractionated heparin therapy in the intensive care unit using a point-of-care aptt: a comparative, longitudinal observational study with laboratory-based aptt and anti-xa activity measurement |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8911237/ https://www.ncbi.nlm.nih.gov/pubmed/35268436 http://dx.doi.org/10.3390/jcm11051338 |
work_keys_str_mv | AT lardinoisbenjamin monitoringofunfractionatedheparintherapyintheintensivecareunitusingapointofcareapttacomparativelongitudinalobservationalstudywithlaboratorybasedapttandantixaactivitymeasurement AT hardymichael monitoringofunfractionatedheparintherapyintheintensivecareunitusingapointofcareapttacomparativelongitudinalobservationalstudywithlaboratorybasedapttandantixaactivitymeasurement AT michauxisabelle monitoringofunfractionatedheparintherapyintheintensivecareunitusingapointofcareapttacomparativelongitudinalobservationalstudywithlaboratorybasedapttandantixaactivitymeasurement AT horlaitgeoffrey monitoringofunfractionatedheparintherapyintheintensivecareunitusingapointofcareapttacomparativelongitudinalobservationalstudywithlaboratorybasedapttandantixaactivitymeasurement AT rotensthomas monitoringofunfractionatedheparintherapyintheintensivecareunitusingapointofcareapttacomparativelongitudinalobservationalstudywithlaboratorybasedapttandantixaactivitymeasurement AT jacqminhugues monitoringofunfractionatedheparintherapyintheintensivecareunitusingapointofcareapttacomparativelongitudinalobservationalstudywithlaboratorybasedapttandantixaactivitymeasurement AT lessiresarah monitoringofunfractionatedheparintherapyintheintensivecareunitusingapointofcareapttacomparativelongitudinalobservationalstudywithlaboratorybasedapttandantixaactivitymeasurement AT bulpapierre monitoringofunfractionatedheparintherapyintheintensivecareunitusingapointofcareapttacomparativelongitudinalobservationalstudywithlaboratorybasedapttandantixaactivitymeasurement AT divealain monitoringofunfractionatedheparintherapyintheintensivecareunitusingapointofcareapttacomparativelongitudinalobservationalstudywithlaboratorybasedapttandantixaactivitymeasurement AT mullierfrancois monitoringofunfractionatedheparintherapyintheintensivecareunitusingapointofcareapttacomparativelongitudinalobservationalstudywithlaboratorybasedapttandantixaactivitymeasurement |